TrialDiabetes, obesity & metabolism2020

Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study).

Gyuri Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.